The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis

Marko Roblek(Institute of Science and Technology Austria), Daria E. Siekhaus(Institute of Science and Technology Austria)
Frontiers in Oncology
February 8, 2022
Cited by 7


Related Papers